Intentar ORO - Gratis

Corning and SGD Pharma inaugurate glass tubing facility in Telangana for pharma packaging

Bio Spectrum

December 2025

Corning Inc and SGD Pharma have announced the inauguration of a new glass tubing facility in Telangana, which will expand pharmaceutical manufacturing in the region.

The new facility will bring together Corning's state-of-the-art Velocity Vial technology and SGD Pharma's vial-converting expertise, helping address capacity challenges and quality requirements in primary glass packaging.

Esta historia es de la edición December 2025 de Bio Spectrum.

Suscríbete a Magzter GOLD para acceder a miles de historias premium seleccionadas y a más de 9000 revistas y periódicos.

¿Ya eres suscriptor? Iniciar sesión

MÁS HISTORIAS DE Bio Spectrum

Ver todo

Bio Spectrum

“The N-FIS market is no longer emerging; it's aligning with where healthcare is headed”

Once viewed as a niche innovation, Needle-Free Injection System (N-FIS) are now evolving into a multi-therapy drug delivery solution, with growing applications across paediatrics, vaccination, in vitro fertilisation (IVF), pain management, and the rapidly expanding GLP-1 therapy segment.

5 mins

July 2026

Bio Spectrum

Imaging Endpoints appoints Srikanth Ayyappan as AVP, Global Marketing

Imaging Endpoints, a Hyderabad-based oncologyfocused imaging contract research organisation (CRO), has appointed Srikanth Ayyappan as Associate Vice President (AVP), Global Marketing.

1 min

July 2026

Bio Spectrum

Cytiva introduces next-gen Biacore 8 series SPR systems for drug discovery

US-based Cytiva, a Danaher company, is introducing the next generation of its Biacore 8 series SPR systems, enabling scientists to generate reliable interaction data faster, as drug discovery grows more complex.

1 min

July 2026

Bio Spectrum

Decentralization and Fragmentation in Bioprocessing Industry

The global bioprocessing industry is undergoing a fundamental transformation.

2 mins

July 2026

Bio Spectrum

Vijay TS steps in as CPO at Redcliffe Labs

Noida-based Redcliffe Labs has announced the appointment of Vijay T. S. as Chief People Officer (CPO), as the company continues to strengthen its organisational foundation to support its next phase of growth and expansion across India.

1 min

July 2026

Bio Spectrum

Dr Sanjay Chaturvedi takes charge as CEO at Matrix Pharmacorn

Telangana-based Matrix Pharmacorp has announced the appointment of Dr Sanjay Chaturvedi as Chief Executive Officer (CEO).

1 min

July 2026

Bio Spectrum

How Mergers and Acquisitions Spell Success for Pharma Companies

The recent acquisition of Organon by Sun Pharmaceutical Industries marks one of the largest pharmaceutical deals involving an Indian company. The all-cash transaction, valued at approximately $11.75 billion, highlights the growing global ambitions of Indian pharmaceutical firms. The latest mergers and acquisitions (M&A) have emerged as a strategic tool for pharmaceutical companies to strengthen market presence, what the future holds and the associated risks. However, challenges remain. Let us delve deep into what goes into these huge M&A transactions and what can be the likely challenges.

6 mins

July 2026

Bio Spectrum

Align Technology to open multi-million dollar manufacturing facility in Hyderabad

Align Technology, Inc., a leading global medical device company that designs, manufactures, and sells the Invisalign System of clear aligners, iTero intraoral scanners and services, and exocad CAD/ CAM software for digital orthodontics and restorative dentistry, has announced plans to open a new manufacturing facility in Hyderabad, in 2027, create more than 300 direct jobs, and spend approximately $200 million in both capital and operational expense over the next several years.

1 min

July 2026

Bio Spectrum

Pharma Fermentation: India's Next Biomanufacturing Opportunity

Driven by increasing demand for biologics, antibiotics, enzymes, biosimilars, and services offered by Contract Development and Manufacturing Organisations (CDMOs) and Contract Research Development and Manufacturing Organisations (CRDMOs), the Indian pharmaceutical fermentation market is witnessing strong growth. The industry is gradually shifting from the production of traditional generic medicines toward higher-value, fermentation-based products, reflecting the growing importance of complex biologics and advanced therapeutics. According to IMARC Group, the India fermentation chemicals market reached $3.2 billion in 2025 and is projected to grow to $5.5 billion by 2034, exhibiting a CAGR of 5.79 per cent during 2026-2034. However, growth alone will not guarantee leadership. India’s ability to build a robust domestic fermentation ecosystem, reduce import dependence, and scale advanced biomanufacturing capabilities will determine whether it can emerge as a global fermentation hub. Let's explore further.

7 mins

July 2026

Bio Spectrum

GVRP & StepsBio unveil new formulations R&D centre in Bengaluru

GVRP (GV Research Platform), a Hyderabadbased research organisation, has announced the inauguration of the GVRP Steps Bio Research Centre (GSRC), a strategic collaboration with Bengalurubased startup Steps Biosciences that marks a significant milestone in India's pharmaceutical R&D landscape.

1 min

July 2026